Results from a combined treatment, comprising Adriamycin, revealed that GLP-Au could reverse the decline in the number of CD4+/CD8+T cells, and generate a strong inhibitory effect on 4T1 tumor growth as well as lung metastasis. This evidence concerns the gene CD8A and neoplasm.